Try our Advanced Search for more refined results

BURLINGTON DRUG CO., INC. et al v. PFIZER INC. et al

Track this case

Case overview

Case Number:

3:12-cv-02389

Court:

New Jersey

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Zahid N. Quraishi

Firms

Companies

Sectors & Industries:

  1. September 12, 2014

    Pfizer Sheds Lipitor Buyers' Class Action In Antitrust MDL

    A New Jersey federal judge on Friday dismissed an antitrust suit in multidistrict litigation challenging a purportedly anti-competitive patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Ltd. over Lipitor, ruling a proposed class of pharmaceutical wholesalers and retailers failed to state a claim.

  2. November 19, 2013

    Daiichi Sankyo Escapes Antitrust MDL Over Generic Lipitor

    A New Jersey federal judge on Monday released Daiichi Sankyo Inc. from multidistrict antitrust litigation challenging a patent infringement settlement between Pfizer Inc. and Ranbaxy Laboratories Inc. over Pfizer's cholesterol drug Lipitor, in which Daiichi Sankyo claimed it had no involvement.

  3. January 17, 2013

    Cohen Milstein Survives DQ Bid In Lipitor MDL

    Cohen Milstein Sellers & Toll PLLC will remain in multidistrict litigation over Pfizer Inc.'s alleged efforts to keep a generic form of Lipitor off the market after a New Jersey federal judge on Thursday rebuffed Blue Cross Blue Shield of Louisiana's bid to oust the firm.

  4. November 19, 2012

    Pfizer Says Lipitor Buyers Can't Bring Antitrust Challenge

    Pfizer Inc. sought Friday to end a class action concerning its purportedly anti-competitive settlement resolving patent litigation over Ranbaxy Inc.'s generic challenge to Pfizer's cholesterol drug Lipitor, telling a New Jersey federal court that the drug retailer plaintiffs lack standing to pursue the case.

  5. October 25, 2012

    Pfizer, Ranbaxy Can't Pause Lipitor Pay-For-Delay Suit

    A New Jersey judge has refused to halt multidistrict antitrust litigation challenging patent infringement settlements Pfizer Inc. reached over its cholesterol treatment Lipitor, ruling that waiting for the U.S. Supreme Court to take and decide similar suits over pay-for-delay deals would stall the case too long.